» Articles » PMID: 10202728

Effect of Carmellose-based Artificial Tears on the Ocular Surface in Eyes After Laser in Situ Keratomileusis

Overview
Journal J Refract Surg
Date 1999 Apr 15
PMID 10202728
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Strategies to minimize intraoperative ocular surface disturbance and accelerate postoperative ocular surface recovery are an important consideration to the surgeon.

Methods: Eighteen eyes of 10 patients were randomized to receive intraoperative and postoperative non-preserved balanced salt solution or non-preserved carboxymethylcellulose-based (carmellose) artificial tears. Presence and severity of McMonnies dry eye symptom survey score primary dry eye symptoms, fluorescein break-up time, and rose bengal staining were graded preoperatively and at 1 day, 1 week and 1 month postoperatively. Conjunctival impression cytology of the perilimbal conjunctiva was performed 1 month after surgery to determine goblet cell density.

Results: McMonnies dry eye symptoms were reported more frequently for the balanced salt solution group at 1 day, 1 week, and 1 month after surgery. Fluorescein break-up time was significantly greater in the carmellose-based group at 1 day (P < .01), 1 week (P = .04), and 1 month (P < .01) after surgery. The rose bengal staining score was significantly greater at 1 day (P < .01) and 1 week (P < .01) postoperatively for the balanced salt solution group. Mean goblet cell density for the carmellose-based group at 1 month postoperatively was significantly greater than that for the balanced salt solution group (P < .01).

Conclusions: Postoperative and intraoperative use of carmellose-based artificial tears resulted in significantly more rapid recovery of the ocular surface after LASIK when compared to balanced salt solution.

Citing Articles

Comparison of Two Topical Lubricants on the Corneal Surface Recovery and Patient Discomfort After Photorefractive Keratectomy.

Canones-Zafra R, Abad J, Castellanos M, Muniz C, Sideroudi H, Teus M Ophthalmol Ther. 2023; 13(1):397-407.

PMID: 37996630 PMC: 10776532. DOI: 10.1007/s40123-023-00847-1.


Refractive surgery and dry eye - An update.

Nair S, Kaur M, Sharma N, Titiyal J Indian J Ophthalmol. 2023; 71(4):1105-1114.

PMID: 37026241 PMC: 10276666. DOI: 10.4103/IJO.IJO_3406_22.


A combination of CMC and α-MSH inhibited ROS activated NLRP3 inflammasome in hyperosmolarity stressed HCECs and scopolamine-induced dry eye rats.

Lv Y, Chu C, Liu K, Ru Y, Zhang Y, Lu X Sci Rep. 2021; 11(1):1184.

PMID: 33441928 PMC: 7807058. DOI: 10.1038/s41598-020-80849-2.


Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose.

Wallerstein A, Jackson W, Chambers J, Moezzi A, Lin H, Simmons P Clin Ophthalmol. 2018; 12:839-848.

PMID: 29765198 PMC: 5944453. DOI: 10.2147/OPTH.S163744.


Topical Osmoprotectant for the Management of Postrefractive Surgery-Induced Dry Eye Symptoms: A Randomised Controlled Double-Blind Trial.

Hazarbassanov R, Queiroz-Hazarbassanov N, Barros J, Gomes J J Ophthalmol. 2018; 2018:4324590.

PMID: 29675272 PMC: 5838485. DOI: 10.1155/2018/4324590.